Safety and tolerability of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: a meta-analysis of randomized controlled trials

Journal of Cancer Research and Clinical Oncology
Wenxin LuoWeimin Li

Abstract

Significant improvement in survival outcome with the programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) inhibitors has been shown in advanced non-small cell lung cancer (NSCLC) patients compared with chemotherapy. However, the full spectrum of toxic events of PD-1/PD-L1 inhibitors was not well characterized. We conducted a comprehensive meta-analysis to state the safety profile of PD-1/PD-L1 inhibitors in NSCLC, and identify the exact incidence and relative risk (RR) of both summary and detailed AEs. Electronic databases (PubMed, EMBASE and the Cochrane library databases) and major conference proceedings were systematically searched for all clinical trials in lung cancer using PD-1/PD-L1 inhibitors. Eligible studies included randomized controlled trials (RCTs) comparing PD-1/PD-L1 inhibitors with chemotherapy in NSCLC patients reporting all-grade (1-4) or high-grade (3-4) AEs [toxic symptoms, hematologic toxicities, and immune-related AEs (irAEs)], treatment discontinuation due to toxicities, or toxic deaths. The pooled incidence, RR, and corresponding 95% confidence interval (CI) of toxicity outcomes were calculated. A total of 4413 patients from 8 RCTs (3 with nivolumab; 2 with atezolizumab, and 3 with pembrolizuma) ...Continue Reading

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Jul 10, 2014·Journal of the National Cancer Institute·Bryce B ReeveDeborah Watkins Bruner
Sep 16, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J NaidooJ D Wolchok
Nov 13, 2015·American Journal of Clinical Oncology·Elizabeth I Buchbinder, Anupam Desai
Jan 15, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J M MichotO Lambotte
Jul 21, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sophie Cousin, Antoine Italiano
Oct 11, 2016·The New England Journal of Medicine·Martin ReckUNKNOWN KEYNOTE-024 Investigators
Apr 6, 2017·Journal of Biomedical Science·Yoshiko IwaiTasuku Honjo
Apr 19, 2018·Annals of Translational Medicine·Young Kwang ChaeFrancis J Giles
May 23, 2018·Journal of the National Comprehensive Cancer Network : JNCCN·John A Thompson

❮ Previous
Next ❯

Citations

Oct 5, 2019·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Laura Lorenzo-Sanz, Purificación Muñoz
Mar 4, 2020·Expert Opinion on Drug Safety·Alexandra M HaughDouglas B Johnson
Mar 5, 2020·Expert Opinion on Drug Safety·José Mª Mazarico GallegoLuis Paz-Ares
Aug 20, 2019·Journal of the National Cancer Institute. Monographs·Dorothy M K Keefe, Emma H Bateman
Jun 27, 2020·Journal of Biochemical and Molecular Toxicology·Nilufer Ozdemir KutbayMehmet Erdogan
May 21, 2020·Wiener klinische Wochenschrift·Lucian BeerHelmut Prosch
Aug 9, 2019·Journal of the Peripheral Nervous System : JPNS·Dimitri PsimarasAndreas A Argyriou
Sep 11, 2020·Case Reports in Oncological Medicine·M L VickersR Chew
Nov 20, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Y YangH Ge
Mar 4, 2021·International Journal of Clinical Oncology·Shoko KawaiYukio Hosomi
Mar 3, 2021·Revue neurologique·R Bonomo, G Cavaletti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.